Jane Street Group, LLC United Therapeutics Corp Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $12.7 Million - $14.8 Million	40,800 New	40,800 $14.6 Million
Q1 2022 May 17, 2022	BUY	$166.16 - $213.96 $6.4 Million - $8.24 Million	38,500 Added 152.78%	63,700 $11.4 Million
Q4 2021 Feb 15, 2022	BUY	$184.32 - $216.08 $866,304 - $1.02 Million	4,700 Added 22.93%	25,200 $5.45 Million
Q3 2021 Nov 16, 2021	SELL	$179.86 - $214.88 $4.75 Million - $5.67 Million	-26,400 Reduced 56.29%	20,500 $3.78 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $5.03 Million - $6.25 Million	29,500 Added 169.54%	46,900 $8.41 Million
Q1 2021 May 18, 2021	BUY	$153.94 - $174.85 $246,304 - $279,760	1,600 Added 10.13%	17,400 $2.91 Million
Q4 2020 Feb 17, 2021	SELL	$101.87 - $151.79 $305,610 - $455,370	-3,000 Reduced 15.96%	15,800 $2.4 Million
Q3 2020 Nov 17, 2020	BUY	$99.9 - $121.13 $89,910 - $109,017	900 Added 5.03%	18,800 $1.9 Million
Q2 2020 Aug 17, 2020	BUY	$92.74 - $125.82 $1.48 Million - $2.01 Million	16,000 Added 842.11%	17,900 $2.17 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $217,740 - $259,939	1,900	1,900 $223,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.